www.tevapharm.com Open in urlscan Pro
45.60.155.76  Public Scan

Submitted URL: http://www.tevapharm.com/
Effective URL: https://www.tevapharm.com/
Submission: On October 01 via manual from PH — Scanned from DE

Form analysis 1 forms found in the DOM

GET /en/tevapharm/search-results/

<form action="/en/tevapharm/search-results/" class="gw-page-search__form" method="get" novalidate="" role="search">
  <fieldset class="gw-page-search__set">
    <label class="sr-only" for="sg-2d114b">Search</label>
    <input id="sg-2d114b" autocomplete="off" class="gw-page-search__input" data-mobileresults="4" data-desktopresults="7" data-tabindex-collapsed="4" placeholder="type your search" aria-label="type your search" required="" type="search" value="">
    <div class="gw-page-search__btn">
      <button type="submit" data-tabindex-collapsed="4" class="vi-btn vi-btn-search"> Search </button>
    </div>
  </fieldset>
  <div class="gw-page-search__clear">
    <div class="gw-page-search__clear-inset">
      <div class="gw-page-search__clear-btn">
        <button type="reset" class="vi-btn-search vi-btn-search--clear vi-btn"> Clear </button>
      </div>
    </div>
  </div>
</form>

Text Content

We recommend using a newer internet browser, such as Google Chrome or Microsoft
Edge, to optimize your browsing experience.

Close

Skip to main content
Search
Search
Clear
Press to close the select your country window or navigate to it's content


FIND MORE INFORMATION ABOUT TEVA IN YOUR LOCATION, OR CONTACT A LOCAL
REPRESENTATIVE ON OUR LOCAL SITES




NORTH AMERICA

 * Canada
 * United States


INTERNATIONAL MARKETS

 * Argentina
 * Australia
 * Belarus
 * Brazil
 * Chile
 * China
 * Hong Kong SAR
 * India
 * Indonesia
 * Israel
 * Japan
 * Kazakhstan
 * Kyrgyzstan
 * Mexico
 * New Zealand
 * Peru
 * Russia
 * Singapore
 * South Africa
 * South Korea
 * Thailand
 * Turkey
 * Ukraine
 * Uruguay


EUROPE

 * Austria
 * Belgium
 * Bosnia and Herzegovina
 * Bulgaria
 * Croatia
 * Czech Republic
 * Denmark
 * Estonia
 * Finland
 * France
 * Germany
 * Greece
 * Hungary
 * Iceland
 * Ireland
 * Italy
 * Latvia
 * Lithuania
 * Macedonia
 * Malta
 * Netherlands
 * Norway
 * Poland
 * Portugal
 * Romania
 * Serbia
 * Slovakia
 * Slovenia
 * Spain
 * Sweden
 * Switzerland
 * United Kingdom

NORTH AMERICA

Toggle
 * Canada
 * United States

INTERNATIONAL MARKETS

Toggle
 * Argentina
 * Australia
 * Belarus
 * Brazil
 * Chile
 * China
 * Hong Kong SAR
 * India
 * Indonesia
 * Israel
 * Japan
 * Kazakhstan
 * Kyrgyzstan
 * Mexico
 * New Zealand
 * Peru
 * Russia
 * Singapore
 * South Africa
 * South Korea
 * Thailand
 * Turkey
 * Ukraine
 * Uruguay

EUROPE

Toggle
 * Austria
 * Belgium
 * Bosnia and Herzegovina
 * Bulgaria
 * Croatia
 * Czech Republic
 * Denmark
 * Estonia
 * Finland
 * France
 * Germany
 * Greece
 * Hungary
 * Iceland
 * Ireland
 * Italy
 * Latvia
 * Lithuania
 * Macedonia
 * Malta
 * Netherlands
 * Norway
 * Poland
 * Portugal
 * Romania
 * Serbia
 * Slovakia
 * Slovenia
 * Spain
 * Sweden
 * Switzerland
 * United Kingdom

Close
 * Investors
 * News & Media

Select your location
Search
 * Our Company Show Submenu
    * Our Purpose
    * Leadership and Corporate Governance Show Submenu
       * Corporate Officers
       * Board of Directors
       * Governance & Policy Documents
   
    * Our Values
    * Teva Facts & Figures
    * Our History
    * Teva’s Global Supply Chain
    * Compliance and Integrity
   
   As a global leader in generic medicines with a strong innovative portfolio,
   we are all in for better health.

 * Product Focus Show Submenu
    * Generic Medicines
    * Innovative Therapeutic Areas
    * Biopharmaceuticals
    * Research & Development Show Submenu
       * Our Pipeline
       * Clinical Trials
       * Collaborative Research & ISS
   
    * Medical Information
    * Consumer Healthcare
    * Out-Licensing Generic Pharmaceuticals
    * Teva api
    * Quality Products
   
   Quality, accessibility, and innovation, without compromise

 * Patients & Caregivers Show Submenu
    * Life Effects: Patient Stories
    * Caregiver Resources
    * Humanizing Health
    * Patient Safety
    * Antimicrobial Resistance
    * Clinical Trials
   
   

 * Our Impact Show Submenu
    * Healthy Future Progress Report
    * Access to Medicine
    * Protecting our Planet
    * Ethics & Compliance
    * Economic Impact
    * Responsible Suppliers
    * Community Giving
   
   Acting responsibly and ethically in all we do helps ensure our
   sustainability—allowing Teva to provide treatments to those who need them for
   years to come.

 * Your Career Show Submenu
    * What we do
    * Inclusion & Diversity Show Submenu
       * Gender Equality
       * Celebrating Pride at Teva
   
    * Life at Teva
    * Growth at Teva
    * Benefits & Wellbeing
    * Changing Industry
    * How we Hire
    * Our People
   
   Working at Teva is not just a job, it’s so much more than that. Here, you get
   to spend each day helping millions of people around the world enjoy healthier
   lives. At the same time, you’ll be joining a dedicated team, united by the
   strong sense that we’re building something greater than ourselves.

 * Contact Us


Menu



WE ARE ALL IN FOR BETTER HEALTH


WHAT ARE THE 3 BIGGEST ELEMENTS SHAPING CLINICAL DEVELOPMENT TODAY?

Eran Harary , SVP, Head of Global Early Clinical Development, identifies key
trends in the Clinical development area.

Discover more What are the 3 biggest elements shaping clinical development
today?


MEDICAL SPECIALISTS WE ALL NEED BUT NEVER SEE: SAFETY PHYSICIANS

While most people consult medical specialists at some point in their lifelong
healthcare journey, there is one medical specialist almost everyone relies on
but we never see in a doctor’s office: safety physicians.

Discover more Medical Specialists We All Need but Never See: Safety Physicians


PRESS RELEASES

September 30, 2024


TEVA TO HOST CONFERENCE CALL TO DISCUSS THIRD QUARTER 2024 FINANCIAL RESULTS AT
8 A.M. ET ON NOVEMBE...

Teva to Host Conference Call to Discuss Third Quarter 2024 Financial Results at
8 a.m. ET on November 6,
September 23, 2024


TEVA ANNOUNCES LONG TERM EFFICACY AND SAFETY OF DEUTETRABENAZINE IN EUROPEAN
PATIENTS WITH DEBILITAT...

Teva Announces Long Term Efficacy and Safety of Deutetrabenazine in European
Patients with Debilitating M
September 21, 2024


TEVA PRESENTS NEW PHASE 3 EFFICACY, SAFETY AND TOLERABILITY DATA FROM SOLARIS
TRIAL EVALUATING TEV-‘...

Teva Presents New Phase 3 Efficacy, Safety and Tolerability Data from SOLARIS
Trial Evaluating TEV-‘749 (
September 21, 2024


NEW DATA PROVIDE TREATMENT INSIGHTS INTO OPTIONS FOR SWITCHING ADULT PATIENTS
DIAGNOSED WITH SCHIZOP...

New Data Provide Treatment Insights into Options for Switching Adult Patients
Diagnosed with Schizophreni
September 11, 2024


TEVA TO PRESENT AT THE BANK OF AMERICA 2024 GLOBAL HEALTHCARE CONFERENCE

Teva to Present at the Bank of America 2024 Global Healthcare Conference
August 26, 2024


TEVA TO PRESENT AT THE MORGAN STANLEY 22ND ANNUAL GLOBAL HEALTHCARE CONFERENCE

Teva to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
July 31, 2024


TEVA ANNOUNCES STRONG GROWTH IN SECOND QUARTER REVENUES MAINLY DRIVEN BY
GENERICS PRODUCTS IN ALL RE...

Teva Announces Strong Growth in Second Quarter Revenues mainly driven by
Generics Products in All Regions and AUSTEDO®; Raises 2024 Financial Guidance
July 25, 2024


TEVA AND SANOFI ANNOUNCE ACCELERATED TIMELINE FOR ANTI-TL1A PHASE 2B PROGRAM IN
PATIENTS WITH INFLAM...

Teva and Sanofi Announce Accelerated Timeline for Anti-TL1A Phase 2b Program in
Patients with Inflammator
July 18, 2024


TEVA ANNOUNCES FIRST PHASE 3 EVIDENCE OF EFFICACY AND SAFETY OF AN ANTI-CGRP
MONOCLONAL ANTIBODY IN ...

Teva Announces First Phase 3 Evidence of Efficacy and Safety of an Anti-CGRP
Monoclonal Antibody in Child
July 02, 2024


TEVA TO HOST CONFERENCE CALL TO DISCUSS SECOND QUARTER 2024 FINANCIAL RESULTS AT
8 A.M. ET ON JULY 3...

Teva to Host Conference Call to Discuss Second Quarter 2024 Financial Results at
8 a.m. ET on July 31, 20
September 30, 2024


TEVA TO HOST CONFERENCE CALL TO DISCUSS THIRD QUARTER 2024 FINANCIAL RESULTS AT
8 A.M. ET ON NOVEMBE...

Teva to Host Conference Call to Discuss Third Quarter 2024 Financial Results at
8 a.m. ET on November 6,
September 23, 2024


TEVA ANNOUNCES LONG TERM EFFICACY AND SAFETY OF DEUTETRABENAZINE IN EUROPEAN
PATIENTS WITH DEBILITAT...

Teva Announces Long Term Efficacy and Safety of Deutetrabenazine in European
Patients with Debilitating M
September 21, 2024


TEVA PRESENTS NEW PHASE 3 EFFICACY, SAFETY AND TOLERABILITY DATA FROM SOLARIS
TRIAL EVALUATING TEV-‘...

Teva Presents New Phase 3 Efficacy, Safety and Tolerability Data from SOLARIS
Trial Evaluating TEV-‘749 (
September 21, 2024


NEW DATA PROVIDE TREATMENT INSIGHTS INTO OPTIONS FOR SWITCHING ADULT PATIENTS
DIAGNOSED WITH SCHIZOP...

New Data Provide Treatment Insights into Options for Switching Adult Patients
Diagnosed with Schizophreni
September 11, 2024


TEVA TO PRESENT AT THE BANK OF AMERICA 2024 GLOBAL HEALTHCARE CONFERENCE

Teva to Present at the Bank of America 2024 Global Healthcare Conference
August 26, 2024


TEVA TO PRESENT AT THE MORGAN STANLEY 22ND ANNUAL GLOBAL HEALTHCARE CONFERENCE

Teva to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
July 31, 2024


TEVA ANNOUNCES STRONG GROWTH IN SECOND QUARTER REVENUES MAINLY DRIVEN BY
GENERICS PRODUCTS IN ALL RE...

Teva Announces Strong Growth in Second Quarter Revenues mainly driven by
Generics Products in All Regions and AUSTEDO®; Raises 2024 Financial Guidance
July 25, 2024


TEVA AND SANOFI ANNOUNCE ACCELERATED TIMELINE FOR ANTI-TL1A PHASE 2B PROGRAM IN
PATIENTS WITH INFLAM...

Teva and Sanofi Announce Accelerated Timeline for Anti-TL1A Phase 2b Program in
Patients with Inflammator
July 18, 2024


TEVA ANNOUNCES FIRST PHASE 3 EVIDENCE OF EFFICACY AND SAFETY OF AN ANTI-CGRP
MONOCLONAL ANTIBODY IN ...

Teva Announces First Phase 3 Evidence of Efficacy and Safety of an Anti-CGRP
Monoclonal Antibody in Child
July 02, 2024


TEVA TO HOST CONFERENCE CALL TO DISCUSS SECOND QUARTER 2024 FINANCIAL RESULTS AT
8 A.M. ET ON JULY 3...

Teva to Host Conference Call to Discuss Second Quarter 2024 Financial Results at
8 a.m. ET on July 31, 20
September 30, 2024


TEVA TO HOST CONFERENCE CALL TO DISCUSS THIRD QUARTER 2024 FINANCIAL RESULTS AT
8 A.M. ET ON NOVEMBE...

Teva to Host Conference Call to Discuss Third Quarter 2024 Financial Results at
8 a.m. ET on November 6,
September 23, 2024


TEVA ANNOUNCES LONG TERM EFFICACY AND SAFETY OF DEUTETRABENAZINE IN EUROPEAN
PATIENTS WITH DEBILITAT...

Teva Announces Long Term Efficacy and Safety of Deutetrabenazine in European
Patients with Debilitating M
September 21, 2024


TEVA PRESENTS NEW PHASE 3 EFFICACY, SAFETY AND TOLERABILITY DATA FROM SOLARIS
TRIAL EVALUATING TEV-‘...

Teva Presents New Phase 3 Efficacy, Safety and Tolerability Data from SOLARIS
Trial Evaluating TEV-‘749 (
September 21, 2024


NEW DATA PROVIDE TREATMENT INSIGHTS INTO OPTIONS FOR SWITCHING ADULT PATIENTS
DIAGNOSED WITH SCHIZOP...

New Data Provide Treatment Insights into Options for Switching Adult Patients
Diagnosed with Schizophreni
September 11, 2024


TEVA TO PRESENT AT THE BANK OF AMERICA 2024 GLOBAL HEALTHCARE CONFERENCE

Teva to Present at the Bank of America 2024 Global Healthcare Conference
August 26, 2024


TEVA TO PRESENT AT THE MORGAN STANLEY 22ND ANNUAL GLOBAL HEALTHCARE CONFERENCE

Teva to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
July 31, 2024


TEVA ANNOUNCES STRONG GROWTH IN SECOND QUARTER REVENUES MAINLY DRIVEN BY
GENERICS PRODUCTS IN ALL RE...

Teva Announces Strong Growth in Second Quarter Revenues mainly driven by
Generics Products in All Regions and AUSTEDO®; Raises 2024 Financial Guidance
July 25, 2024


TEVA AND SANOFI ANNOUNCE ACCELERATED TIMELINE FOR ANTI-TL1A PHASE 2B PROGRAM IN
PATIENTS WITH INFLAM...

Teva and Sanofi Announce Accelerated Timeline for Anti-TL1A Phase 2b Program in
Patients with Inflammator
July 18, 2024


TEVA ANNOUNCES FIRST PHASE 3 EVIDENCE OF EFFICACY AND SAFETY OF AN ANTI-CGRP
MONOCLONAL ANTIBODY IN ...

Teva Announces First Phase 3 Evidence of Efficacy and Safety of an Anti-CGRP
Monoclonal Antibody in Child
July 02, 2024


TEVA TO HOST CONFERENCE CALL TO DISCUSS SECOND QUARTER 2024 FINANCIAL RESULTS AT
8 A.M. ET ON JULY 3...

Teva to Host Conference Call to Discuss Second Quarter 2024 Financial Results at
8 a.m. ET on July 31, 20
View all press releases
Previous
Next


HEALTHY FUTURE: SUSTAINABILITY AT TEVA


TEVA NAMED ONE OF THE WORLD’S MOST SUSTAINABLE COMPANIES

TIME magazine and data firm Statista measured how companies are living up to
their promises to protect our planet. We’re honored to be recognized for our
efforts and ambitions.

Discover more Teva Named One of the World’s Most Sustainable Companies

--------------------------------------------------------------------------------


TAKE A CLOSER LOOK AT WHAT WE DO


HOW CAN WE USE AI TO MAKE MEDICINES MORE EFFICIENTLY?



Discover more


3 TRENDS I’M WATCHING IN PATIENT SAFETY



Discover more


"I BELIEVE THAT WELLBEING STARTS WITH YOUR INNER SELF"



Discover more


NO MOUNTAIN TOO HIGH FOR WELLBEING



Discover more


TEVA’S TOP GRADUATES: FROM ACADEMIC LEARNING TO BUSINESS LEADERSHIP



Discover more


PIVOT TO GROWTH: THE TEVA JOURNEY



Discover more


WHAT TO KNOW ABOUT SCHIZOPHRENIA



Discover more


CHALLENGING GENDER STEREOTYPES TO DRIVE EXCELLENCE



Discover more


EMPOWERING PEOPLE TO TAKE BETTER CARE OF THEMSELVES



Discover more


7 WAYS TEVA IS COLLABORATING TO INNOVATE



Discover more


CARING FOR CAREGIVERS: HEATHER’S JOURNEY WITH HD



Discover more


"WE SPEND A LOT OF TIME AT WORK; WE SHOULD ENJOY IT."



Discover more


DIVERSITY FUELS INNOVATION IN TEVA’S R&D MANAGEMENT TEAM



Discover more


COMPLEX GENERICS: FACTS, FIGURES AND WHO THEY BENEFIT



Read more


TEVA + OUR SUPPLIERS = A GREATER POSITIVE IMPACT



Discover more


TOOLS & RESOURCES FOR CAREGIVERS



Discover more


HOW CAN WE USE AI TO MAKE MEDICINES MORE EFFICIENTLY?



Discover more


3 TRENDS I’M WATCHING IN PATIENT SAFETY



Discover more


"I BELIEVE THAT WELLBEING STARTS WITH YOUR INNER SELF"



Discover more


NO MOUNTAIN TOO HIGH FOR WELLBEING



Discover more


TEVA’S TOP GRADUATES: FROM ACADEMIC LEARNING TO BUSINESS LEADERSHIP



Discover more


PIVOT TO GROWTH: THE TEVA JOURNEY



Discover more


WHAT TO KNOW ABOUT SCHIZOPHRENIA



Discover more


CHALLENGING GENDER STEREOTYPES TO DRIVE EXCELLENCE



Discover more


EMPOWERING PEOPLE TO TAKE BETTER CARE OF THEMSELVES



Discover more


7 WAYS TEVA IS COLLABORATING TO INNOVATE



Discover more


CARING FOR CAREGIVERS: HEATHER’S JOURNEY WITH HD



Discover more


"WE SPEND A LOT OF TIME AT WORK; WE SHOULD ENJOY IT."



Discover more


DIVERSITY FUELS INNOVATION IN TEVA’S R&D MANAGEMENT TEAM



Discover more


COMPLEX GENERICS: FACTS, FIGURES AND WHO THEY BENEFIT



Read more


TEVA + OUR SUPPLIERS = A GREATER POSITIVE IMPACT



Discover more


TOOLS & RESOURCES FOR CAREGIVERS



Discover more


HOW CAN WE USE AI TO MAKE MEDICINES MORE EFFICIENTLY?



Discover more


3 TRENDS I’M WATCHING IN PATIENT SAFETY



Discover more


"I BELIEVE THAT WELLBEING STARTS WITH YOUR INNER SELF"



Discover more


NO MOUNTAIN TOO HIGH FOR WELLBEING



Discover more


TEVA’S TOP GRADUATES: FROM ACADEMIC LEARNING TO BUSINESS LEADERSHIP



Discover more


PIVOT TO GROWTH: THE TEVA JOURNEY



Discover more


WHAT TO KNOW ABOUT SCHIZOPHRENIA



Discover more


CHALLENGING GENDER STEREOTYPES TO DRIVE EXCELLENCE



Discover more


EMPOWERING PEOPLE TO TAKE BETTER CARE OF THEMSELVES



Discover more


7 WAYS TEVA IS COLLABORATING TO INNOVATE



Discover more


CARING FOR CAREGIVERS: HEATHER’S JOURNEY WITH HD



Discover more


"WE SPEND A LOT OF TIME AT WORK; WE SHOULD ENJOY IT."



Discover more


DIVERSITY FUELS INNOVATION IN TEVA’S R&D MANAGEMENT TEAM



Discover more


COMPLEX GENERICS: FACTS, FIGURES AND WHO THEY BENEFIT



Read more


TEVA + OUR SUPPLIERS = A GREATER POSITIVE IMPACT



Discover more


TOOLS & RESOURCES FOR CAREGIVERS



Discover more
View all stories
Previous
Next


CAREERS AT TEVA


MAKE A DIFFERENCE TO PEOPLE'S HEALTH, EVERY DAY

Working at Teva is not just a job, it’s so much more than that. Here, you get to
spend each day helping millions of people around the world enjoy healthier
lives. At the same time, you’ll be joining a dedicated team, united by the
strong sense that we’re building something greater than ourselves

Explore a Teva Career Make a difference to people's health, every day

--------------------------------------------------------------------------------


LIFE EFFECTS STORIES FROM PATIENTS AND CAREGIVERS


MY 7 COPING STRATEGIES FOR LIVING WITH DEPRESSION



Discover more


GETTING COMFORTABLE DATING WITH SCHIZOPHRENIA – SOME OF MY CHALLENGES AND WINS



Discover more


SURVIVAL OF THE FOCUSED: HOW TACHYCARDIA PUSHED ME TO MAKE HEART-HEALTHY
LIFESTYLE CHANGES



Discover more


HOW I HELP MANAGE MY CHRONIC PAIN WITH EXERCISE



Discover more


SEASONAL ALLERGIES OR MIGRAINE? KNOW THE DIFFERENCE



Discover more


MANAGING CHILDBIRTH AND BREASTFEEDING WITH DEPRESSION AND ANXIETY



Discover more


ASTHMA MYTHS VS. PERSONAL EXPERIENCE – HOW DO THE MYTHS HOLD UP?



Read more


LEARNING ESSENTIAL CAREGIVER COMMUNICATION SKILLS



Read more


4 THINGS EVERYONE CAN DO TO COMBAT MENTAL HEALTH STIGMA



Read more


5 TIPS FOR BETTER ASTHMA CONTROL



Read more


ADHD AND IMPULSIVITY: 6 WAYS TO STAY IN CONTROL



Read more


HOW TO DISCUSS UNCOMFORTABLE TOPICS AS A CAREGIVER



Read more


“SAY WHAT?!” HOW TO NIP UNWANTED CANCER ADVICE IN THE BUD



Read more


MIGRAINE AND BRAIN FOG



Read more


CAREGIVER TIME MANAGEMENT – ALWAYS A WORK IN PROCESS



Read more


KEEPING IT SIMPLE: REDUCING HAZARDS AS HD PROGRESSES



Read more


THE PROBLEM WITH NOT TALKING ABOUT HEART FAILURE



Read more


MY 7 COPING STRATEGIES FOR LIVING WITH DEPRESSION



Discover more


GETTING COMFORTABLE DATING WITH SCHIZOPHRENIA – SOME OF MY CHALLENGES AND WINS



Discover more


SURVIVAL OF THE FOCUSED: HOW TACHYCARDIA PUSHED ME TO MAKE HEART-HEALTHY
LIFESTYLE CHANGES



Discover more


HOW I HELP MANAGE MY CHRONIC PAIN WITH EXERCISE



Discover more


SEASONAL ALLERGIES OR MIGRAINE? KNOW THE DIFFERENCE



Discover more


MANAGING CHILDBIRTH AND BREASTFEEDING WITH DEPRESSION AND ANXIETY



Discover more


ASTHMA MYTHS VS. PERSONAL EXPERIENCE – HOW DO THE MYTHS HOLD UP?



Read more


LEARNING ESSENTIAL CAREGIVER COMMUNICATION SKILLS



Read more


4 THINGS EVERYONE CAN DO TO COMBAT MENTAL HEALTH STIGMA



Read more


5 TIPS FOR BETTER ASTHMA CONTROL



Read more


ADHD AND IMPULSIVITY: 6 WAYS TO STAY IN CONTROL



Read more


HOW TO DISCUSS UNCOMFORTABLE TOPICS AS A CAREGIVER



Read more


“SAY WHAT?!” HOW TO NIP UNWANTED CANCER ADVICE IN THE BUD



Read more


MIGRAINE AND BRAIN FOG



Read more


CAREGIVER TIME MANAGEMENT – ALWAYS A WORK IN PROCESS



Read more


KEEPING IT SIMPLE: REDUCING HAZARDS AS HD PROGRESSES



Read more


THE PROBLEM WITH NOT TALKING ABOUT HEART FAILURE



Read more


MY 7 COPING STRATEGIES FOR LIVING WITH DEPRESSION



Discover more


GETTING COMFORTABLE DATING WITH SCHIZOPHRENIA – SOME OF MY CHALLENGES AND WINS



Discover more


SURVIVAL OF THE FOCUSED: HOW TACHYCARDIA PUSHED ME TO MAKE HEART-HEALTHY
LIFESTYLE CHANGES



Discover more


HOW I HELP MANAGE MY CHRONIC PAIN WITH EXERCISE



Discover more


SEASONAL ALLERGIES OR MIGRAINE? KNOW THE DIFFERENCE



Discover more


MANAGING CHILDBIRTH AND BREASTFEEDING WITH DEPRESSION AND ANXIETY



Discover more


ASTHMA MYTHS VS. PERSONAL EXPERIENCE – HOW DO THE MYTHS HOLD UP?



Read more


LEARNING ESSENTIAL CAREGIVER COMMUNICATION SKILLS



Read more


4 THINGS EVERYONE CAN DO TO COMBAT MENTAL HEALTH STIGMA



Read more


5 TIPS FOR BETTER ASTHMA CONTROL



Read more


ADHD AND IMPULSIVITY: 6 WAYS TO STAY IN CONTROL



Read more


HOW TO DISCUSS UNCOMFORTABLE TOPICS AS A CAREGIVER



Read more


“SAY WHAT?!” HOW TO NIP UNWANTED CANCER ADVICE IN THE BUD



Read more


MIGRAINE AND BRAIN FOG



Read more


CAREGIVER TIME MANAGEMENT – ALWAYS A WORK IN PROCESS



Read more


KEEPING IT SIMPLE: REDUCING HAZARDS AS HD PROGRESSES



Read more


THE PROBLEM WITH NOT TALKING ABOUT HEART FAILURE



Read more
View All Stories
Previous
Next


AT TEVA, WE FOCUS ON THE THINGS THAT COUNT

Watch now
 


AT TEVA, WE STRIVE TO DELIVER QUALITY MEDICINES TO PATIENTS AROUND THE WORLD
WITH INTEGRITY AND ETHICAL BUSINESS PRACTICES. WHAT WE DO IS IMPORTANT, BUT HOW
WE DO IT IS JUST AS IMPORTANT. LEARN MORE:

TEVA CODE OF CONDUCT



SUPPLIER CODE OF CONDUCT



ENVIRONMENTAL, SOCIAL AND GOVERNANCE AT TEVA



ALL CORPORATE GOVERNANCE & POLICY DOCUMENTS


 * Contact Us
 * Terms of Use
 * Social Media Guidelines
 * Teva api
 * Medis

 * Sitemap
 * Data Privacy
 * Pharmacovigilance Privacy Notice
 * Accessibility Statement
 * Cookie Settings

FOLLOW US

 * Facebook
 * Twitter
 * Linkedin

 * 
   
   Youtube

Copyright © 2024 Teva Pharmaceutical Industries Ltd.

Click here to back to top


YOU ARE ABOUT TO LEAVE THE TEVA PHARMACEUTICALS GLOBAL WEBSITE

Close

The website you are about to access may be governed by different regional
policies, regulations or advertising codes. Please be sure to read the privacy
policy and terms of use of the websites that you visit.

Teva Pharmaceuticals is not responsible for the accuracy or compliance with laws
of information on any third party websites.

Do you wish to proceed?

Go to site





PRIVACY PREFERENCE CENTRE




 * YOUR PRIVACY


 * STRICTLY NECESSARY COOKIES


 * TARGETING COOKIES


 * FUNCTIONAL COOKIES


 * PERFORMANCE COOKIES

YOUR PRIVACY

When you visit any website, it may store or retrieve information on your
browser, mostly in the form of cookies. This information might be about you,
your preferences or your device and is mostly used to make the site work as you
expect it to. The information does not usually directly identify you, but it can
give you a more personalized web experience. Because we respect your right to
privacy, you can choose not to allow some types of cookies. Click on the
different category headings to find out more and change our default settings.
However, blocking some types of cookies may impact your experience of the site
and the services we are able to offer.
More information

STRICTLY NECESSARY COOKIES

Always Active

These cookies are necessary for the website to function and cannot be switched
off in our systems. They are usually only set in response to actions made by you
which amount to a request for services, such as setting your privacy
preferences, logging in or filling in forms. You can set your browser to block
or alert you about these cookies, but some parts of the site will not then work.

Cookies Details‎

TARGETING COOKIES

Targeting Cookies Inactive


These cookies may be set through our site by our advertising partners. They may
be used by those companies to build a profile of your interests and show you
relevant adverts on other sites. They do not store directly personal
information, but are based on uniquely identifying your browser and internet
device. If you do not allow these cookies, you will experience less targeted
advertising.

Cookies Details‎

FUNCTIONAL COOKIES

Functional Cookies Inactive


These cookies enable the website to provide enhanced functionality and
personalisation. They may be set by us or by third party providers whose
services we have added to our pages. If you do not allow these cookies then some
or all of these services may not function properly.

Cookies Details‎

PERFORMANCE COOKIES

Performance Cookies Inactive


These cookies allow us to count visits and traffic sources so we can measure and
improve the performance of our site. They help us to know which pages are the
most and least popular and see how visitors move around the site. All
information these cookies collect is aggregated and therefore may be
non-directly identifiable. If you do not allow these cookies we will not know
when you have visited our site, and will not be able to monitor its performance.

Cookies Details‎
Back Button Back



Vendor Search
Filter Button
Consent Leg.Interest
checkbox label label
checkbox label label
checkbox label label

 * View Third Party Cookies
    * Name
      cookie name


Clear
checkbox label label
Apply Cancel
Confirm My Choices
Allow All



COOKIES

We would like to collect some of your data to enhance your browsing experience,
analyse, and measure your engagement with our content. By clicking [Accept] you
consent to this and to sharing this data with our partners, including to serve
you more relevant ads on other websites. If you continue without accepting, this
cannot take place or will be less accurate. You can change your mind at any
time. To find out more about your rights, our practices, the data we collect and
our partners, click here.


AcceptReject AllYour Choices